505 related articles for article (PubMed ID: 27074369)
1. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin.
Lopes M; Shrestha N; Correia A; Shahbazi MA; Sarmento B; Hirvonen J; Veiga F; Seiça R; Ribeiro A; Santos HA
J Control Release; 2016 Jun; 232():29-41. PubMed ID: 27074369
[TBL] [Abstract][Full Text] [Related]
2. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
3. Facilitated nanoscale delivery of insulin across intestinal membrane models.
Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
[TBL] [Abstract][Full Text] [Related]
4. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
5. pH-sensitive chitosan-deoxycholic acid/alginate nanoparticles for oral insulin delivery.
Zhang YW; Tu LL; Tang Z; Wang Q; Zheng GL; Yin LN
Pharm Dev Technol; 2021 Nov; 26(9):943-952. PubMed ID: 34372745
[TBL] [Abstract][Full Text] [Related]
6. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
Liu L; Yang H; Lou Y; Wu JY; Miao J; Lu XY; Gao JQ
Int J Pharm; 2019 Feb; 557():170-177. PubMed ID: 30597264
[TBL] [Abstract][Full Text] [Related]
8. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
Ke Z; Guo H; Zhu X; Jin Y; Huang Y
J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
[TBL] [Abstract][Full Text] [Related]
9. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
10. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
[TBL] [Abstract][Full Text] [Related]
11. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
[TBL] [Abstract][Full Text] [Related]
12. Cp1-11 peptide/insulin complex loaded pH-responsive nanoparticles with enhanced oral bioactivity.
Chen X; Ren Y; Feng Y; Xu X; Tan H; Li J
Int J Pharm; 2019 May; 562():23-30. PubMed ID: 30877031
[TBL] [Abstract][Full Text] [Related]
13. Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin.
Tsai LC; Chen CH; Lin CW; Ho YC; Mi FL
Int J Biol Macromol; 2019 Apr; 126():141-150. PubMed ID: 30586591
[TBL] [Abstract][Full Text] [Related]
14. All-in-one microfluidic assembly of insulin-loaded pH-responsive nano-in-microparticles for oral insulin delivery.
Costa C; Liu Z; Martins JP; Correia A; Figueiredo P; Rahikkala A; Li W; Seitsonen J; Ruokolainen J; Hirvonen SP; Aguiar-Ricardo A; Corvo ML; Santos HA
Biomater Sci; 2020 Jun; 8(12):3270-3277. PubMed ID: 32490443
[TBL] [Abstract][Full Text] [Related]
15. Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid.
Lima IA; Khalil NM; Tominaga TT; Lechanteur A; Sarmento B; Mainardes RM
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):993-1002. PubMed ID: 29842790
[TBL] [Abstract][Full Text] [Related]
16. Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles.
Ling K; Wu H; Neish AS; Champion JA
J Control Release; 2019 Feb; 295():174-186. PubMed ID: 30557649
[TBL] [Abstract][Full Text] [Related]
17. pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery.
Mukhopadhyay P; Chakraborty S; Bhattacharya S; Mishra R; Kundu PP
Int J Biol Macromol; 2015 Jan; 72():640-8. PubMed ID: 25239194
[TBL] [Abstract][Full Text] [Related]
18. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium.
Araújo F; Shrestha N; Shahbazi MA; Fonte P; Mäkilä EM; Salonen JJ; Hirvonen JT; Granja PL; Santos HA; Sarmento B
Biomaterials; 2014 Nov; 35(33):9199-207. PubMed ID: 25109441
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-Coated Alginate Nanoparticles Enhanced Absorption Profile of Insulin Via Oral Administration.
Jaafar MHM; Hamid KA
Curr Drug Deliv; 2019; 16(7):672-686. PubMed ID: 31250754
[TBL] [Abstract][Full Text] [Related]
20. Insulin loaded mucus permeating nanoparticles: Addressing the surface characteristics as feature to improve mucus permeation.
Pereira de Sousa I; Moser T; Steiner C; Fichtl B; Bernkop-Schnürch A
Int J Pharm; 2016 Mar; 500(1-2):236-44. PubMed ID: 26802494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
